ѻý

Jump to Main Content

Advocacy

Policy Statements

The ѻý represents the interests of hematologists and their patients before Congress and the Executive branch, advocating for the best science and practice of hematology. When warranted, ASH issues policy statements on research, practice, training, or quality of care issues that are likely to have an impact on the field.

Submit
Reset

ASH Policy Statement on Coverage of Fertility Treatment in Hematologic Care

Apr 24
2024

Fertility preservation and management is a critical aspect of reproductive health care to safeguard an individual's ability to have children in the future. The primary goal of fertility preservation is to provide options for reproductive life plannin...

Read more

Access to Hematology Care in an Age of Innovation

Apr 02
2024

Access to Hematology Care in an Age of Innovation The ѻý (ASH) believes that all individuals should have access to and be able to afford high-quality, clinically appropriate care, including innovative therapeutics. Hema...

Read more

Statement on a Strong Blood Supply

Sep 13
2022

The ѻý (ASH) represents over 18,000 physicians, scientists, and medical trainees committed to the study of blood and treatment of blood-related diseases. ASH members include clinicians who specialize in treating children a...

Read more

Maternal Rights Policy Statement

Jun 24
2022

Maternal deaths have been increasing in the United States since 2000. According to the Centers for Disease Control and Prevention (CDC), the maternal mortality rate was 20.1 per 100,000 live births in the United States in 2019. The corresponding num...

Read more

Statement in Support of the Value of Scholarly Publishers

Nov 17
2021

As a member of the Council of Medical Specialty Societies (CMSS) and an organization committed to promoting and supporting clinical and scientific research in hematology, the ѻý (ASH) supports the CMSS statement on the val...

Read more

ASH Statement Addressing Diversity, Equity, and Inclusion in Hematology Research, Practice, and Training

Aug 11
2021

The ѻý is committed to addressing and reversing historic inequities in hematology, supporting scientists and clinicians from backgrounds underrepresented in medicine, and elevating diverse voices across our patient and hea...

Read more

ASH Position on Sickle Cell Trait

May 25
2021

ASH Position It is medically inaccurate to claim sickle cell crisis as the cause of death based solely on the presence of sickled cells at autopsy. Sudden death is an extraordinarily rare occurrence in sickle cell trait and the finding of sickle cell...

Read more

ASH Statement in Support of Palliative Blood Transfusions in Hospice Setting

Jun 25
2019

The ѻý (ASH) represents approximately 17,000 physicians, scientists, and medical trainees committed to the study and treatment of blood and blood-related diseases. As an organization of physicians and scientists who care f...

Read more

ASH Statement of Principles on Continuous Certification

Nov 30
2018

Beginning in 2001, the ѻý (ASH) questioned the underlying premise of maintenance of certification. The American Board of Medical Specialties (ABMS) Commission on Continuing Board Certification is taking a much-needed look...

Read more

Statement on Opioid Use in Patients with Hematologic Diseases and Disorders

Apr 18
2018

The ѻý (ASH) represents approximately 17,000 physicians, scientists, and medical trainees committed to the study of blood and treatment of blood-related diseases. ASH members include clinicians who specialize in treating c...

Read more